PUNE, India, November 01, 2022 (GLOBE NEWSWIRE) — The Dermal Filler Market was US$5.31 billion in 2022 and is forecast to reach US$8.74 billion by 2029, growing at a CAGR of 7.4% over the forecast period. Fortune Business Insights™ provides this updated report in its latest report, titled Dermal Fillers Market Forecast, 2022-2029.
Dermal fillers are products used to improve the appearance of the skin. They come in a variety of shapes and sizes and can be filled with a variety of substances. Dermal fillers are used to improve the appearance of wrinkles, scars, and other skin problems.
Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939
industry development
- Galderma announced the re-launch of Sculptra (poly-L-lactic acid injectable) in Europe with an updated administration protocol.
report scope
| report coverage | details |
| forecast period | 2022 to 2029 |
| Forecast period 2022 to 2029 CAGR | 7.4% |
| Value prognosis 2029 | $8.74 billion |
| base year | 2021 |
| Market size in 2022 | $5.31 billion |
| Historical data for | 2018 to 2020 |
| number of pages | 163 |
The dermal filler market is growing steadily as individuals look for ways to improve their appearance. This growth is likely due to the increasing popularity of cosmetic surgery, as well as increasing awareness of the benefits of dermal fillers.
competitive landscape
Major players focus on new product launches to bolster market growth
The market is being consolidated by large companies striving to maintain their position by focusing on new launches. For example in August 2020, Revance Therapeutics, Inc. launched the RHA Dermal Filler Line. It is the first and only FDA-approved dermal filler that can be used in the United States to correct dynamic facial lines and wrinkles. Such proactive strategies are expected to drive the market for years to come.
Click here for the short and long term impact of COVID-19 on this market.
